Spruce Biosciences, Inc. Common Stock (SPRB) — Financial Flexibility Index
Spruce Biosciences, Inc. Common Stock (SPRB) has a Financial Flexibility Index of -1.15x as of June 2026. Free cash flow of $-21.98 Million (operating CF $-22.12 Million minus capex $135.00K) represents -1% of total liabilities ($19.12 Million). Check total reinvestment intensity of Spruce Biosciences, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Spruce Biosciences, Inc. Common Stock Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Spruce Biosciences, Inc. Common Stock across 8 annual periods. For the full cash flow conversion analysis, see SPRB cash flow conversion.
Annual Financial Flexibility Index for Spruce Biosciences, Inc. Common Stock (2018–2025)
Year-by-year free cash flow to debt coverage for Spruce Biosciences, Inc. Common Stock. Explore Spruce Biosciences, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.17x | $-33.33 Million | $-33.33 Million | $10.51 Million | ▲ +7.1% |
| 2024 | -3.41x | $-55.96 Million | $-55.96 Million | $16.39 Million | ▼ -181.6% |
| 2023 | -1.21x | $-33.27 Million | $-33.27 Million | $27.44 Million | ▲ +50.1% |
| 2022 | -2.43x | $-41.67 Million | $-41.68 Million | $17.16 Million | ▼ -2.6% |
| 2021 | -2.37x | $-35.78 Million | $-35.88 Million | $15.12 Million | ▼ -16.1% |
| 2020 | -2.04x | $-27.45 Million | $-27.52 Million | $13.46 Million | ▼ -471.3% |
| 2019 | -0.36x | $-12.61 Million | $-12.62 Million | $35.33 Million | ▲ +5.9% |
| 2018 | -0.38x | $-8.57 Million | $-8.57 Million | $22.58 Million | — |